ENDRA Life Sciences (NDRA) Treasury Shares (2016 - 2022)

ENDRA Life Sciences has disclosed Treasury Shares across 7 years of filings, most recently posting $2.4 million for Q1 2022.

• In Q1 2022, Treasury Shares changed N/A year-over-year to $2.4 million; the TTM figure through Mar 2022 stood at $2.4 million (changed N/A YoY), while the FY2021 annual figure was $121818.0, down 98.05% from the prior year.
• Treasury Shares grew to $2.4 million in Q1 2022, from $121818.0 in the prior quarter.
• Over the last five years, Treasury Shares for NDRA reached as high as $13.5 million in Q4 2019 and fell as low as $121818.0 in Q4 2021.
• The 5-year median for Treasury Shares is $2.6 million (2018), against an average of $5.2 million.
• Annual changes were most pronounced in 2019 — Treasury Shares surged 413.58% — and 2021, when it tumbled 98.05%.
• A 5-year view of Treasury Shares shows it stood at $2.6 million in 2018, then surged by 413.58% to $13.5 million in 2019, then slumped by 53.68% to $6.3 million in 2020, then plunged by 98.05% to $121818.0 in 2021, then surged by 1900.66% to $2.4 million in 2022.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.4 million, $121818.0, and $2.4 million for Q1 2022, Q4 2021, and Q2 2021 respectively.